Skip to content

Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus

Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02283216
Enrollment
0
Registered
2014-11-05
Start date
2015-06-01
Completion date
2017-09-13
Last updated
2019-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

neuromodulation, noninvasive, plasticity, transcranial magnetic stimulation, hearing, hyperacusis

Brief summary

The purpose of the study is to investigate different stimulation parameters for a new noninvasive approach for modulating the brain that could potentially be beneficial for decreasing tinnitus perception. The new approach is called Multimodal Synchronization Therapy (mSync). mSync uses a combination of acoustic stimulation played through headphones and low levels of electrical current delivered via electrodes placed on the surface of different body regions. The timing interval between the acoustic and body stimulation is varied in order to cause different types of changes in the brain. In addition to acoustic and body stimulation, noninvasive cortical stimulation will also be presented as part of mSync to attempt to further modulate or decrease the tinnitus percept. Cortical stimulation will be performed by placing a magnetic coil over a spot on the head and sending a brief magnetic pulse that can travel through the skin and bone to create electrical current inside the head. For this study, different body locations as well as specific timing intervals among acoustic, body, and cortical stimulation will be investigated to identify appropriate parameters that can modulate and potentially decrease tinnitus perception. Different mSync parameters will be investigated across multiple testing sessions (up to 16 weekly sessions) and the tinnitus percept will be closely monitored throughout the study.

Detailed description

This study is not specifically seeking to treat tinnitus but is designed to investigate various mSync parameters that can alter the tinnitus percept. Findings from this study will help identify specific mSync parameters that can be more effective at decreasing or fully suppressing the tinnitus percept that will be systematically explored in a follow-up study.

Interventions

DEVICEnoise sound stimulation (Tucker-Davis Technologies)

Band-limited white noise stimulus, comfortable loudness level, presented via headphones or earphones with Tucker-Davis Technologies device.

DEVICEbody electrical stimulation (Digitimer device)

Single pulse electrical stimulation on different body regions, comfortable current level, presented via surface pads or clips with Digitimer device.

Single pulse magnetic stimulation over frontal cortex, comfortable level at 110% resting motor threshold, presented via magnetic coil with Magstim device.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Have subjective, non-pulsatile, and bothersome tinnitus * Will not start any new tinnitus treatment during the study * Ability to give informed consent and understand study objectives in English * Willing and able to understand and comply with all study-related procedures

Exclusion criteria

* Substantial hearing loss or hyperacusis that may interfere with the study * Medical history of other ear or brain disorders, history of seizures, or currently using any medication or treatments that can cause or increase the chances of seizures * Any implanted medical or metal device, such as a pacemaker, aneurysm clip, or cochlear implant * Pregnant or currently breast-feeding (we need to give all female subjects a pregnancy test because pregnant females and unborn children need extra protection for their safety) * Any handicap that prevents the subject from reliably performing the tests

Design outcomes

Primary

MeasureTime frameDescription
Change in Tinnitus Functional Index Questionnaire ScoreChange from baseline score at 1 week after testing paradigmA series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score.
Change in Minimal Masking LevelChange in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigmA narrowband noise (from 2-12 kHz) is presented to the tinnitus ear and the minimum sound level (in decibel sound pressure level, decibel SPL) is determined that completely masks the tinnitus percept.

Secondary

MeasureTime frameDescription
Change in Tinnitus Subjective DescriptionChange in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigmThe subject describes the quality, characteristics and bothering nature of the tinnitus.
Change in Tinnitus Handicap Inventory Questionnaire ScoreChange from baseline score at 1 week after testing paradigmA series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score.
Daily Tinnitus Journal Entries0, 1, 2, 3, 4, 5, 6, 7 days post-testing paradigmThe subject describes the quality, characteristics and bothering nature of the tinnitus on a daily basis. The subject can also include any unusual or interesting events relating to the tinnitus that he/she feels would be relevant for the study.
Change in Tinnitus Matching (pitch and loudness)Change in baseline pitch and loudness at an expected average of 1.5 hours after testing paradigmThe subject adjusts the loudness and pitch (i.e., frequency) of a sound played to an ear to that of the tinnitus percept.
Change in Tinnitus Rating (0-10, 10 being worst)Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigmThe subject rates the disturbance or bothering nature of the tinnitus.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026